Back to search

Article

Influence of Cytochrome P450 (CYP) 2C8 polymorphisms on the efficacy and tolerability of artesunate-amodiaquine treatment of uncomplicated Plasmodium falciparum malaria in Zanzibar

2021-01-26

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>The antimalarial drug amodiaquine, a commonly used long acting partner drug in artemisinin-based combination therapy, is metabolized to active desethyl-amodiaquine (DEAQ) by cytochrome P450 2C8 (CYP2C8). The <italic>CYP2C8 </italic>gene carries several polymorphisms including the more frequent minor alleles<italic> CYP2C8*2</italic> and <italic>CYP2C8*3</italic>....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3d29a81-bf87-5898-a5e7-d3e4f8b7ac0c
DOI
10.21203/rs.3.rs-104894/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Influence of Cytochrome P450 (CYP) 2C8 polymorphisms on the efficacy and tolerability of artesunate-amodiaquine treatment of uncomplicated Plasmodium falciparum malaria in ZanzibarDOI 10.21203/rs.3.rs-104894/v2
Select a neighboring publication to make it the new centre.